Publication:
Combined ECT and clozapine in treatment-resistant mania

Simple item page
dc.contributor.authorChanpattana W.
dc.date.accessioned2021-04-05T04:33:26Z
dc.date.available2021-04-05T04:33:26Z
dc.date.issued2000
dc.date.issuedBE2543
dc.description.abstractA treatment-resistant manic patient failed to respond to conventional treatment, adjunctive olanzapine (20 mg/day), clozapine (600 mg/day), or ECT alone, but did respond to ECT combined with low dose clozapine (200 mg/day). Maintenance ECT combined with clozapine resulted in a remission over the 18-month period.
dc.format.mimetypeapplication/pdf
dc.identifier.citationJournal of ECT. Vol 16, No.2 (2000), p.204-207
dc.identifier.doi10.1097/00124509-200006000-00013
dc.identifier.issn10950680
dc.identifier.other2-s2.0-0034199344
dc.identifier.urihttps://hdl.handle.net/20.500.14740/7048
dc.rights.holderScopus
dc.subject.otherClozapine
dc.subject.otherNeuroleptic agent
dc.subject.otherAdult
dc.subject.otherArticle
dc.subject.otherBipolar disorder
dc.subject.otherCase report
dc.subject.otherElectroconvulsive therapy
dc.subject.otherHuman
dc.subject.otherLong term care
dc.subject.otherMale
dc.subject.otherMultimodality cancer therapy
dc.subject.otherAdult
dc.subject.otherAntipsychotic Agents
dc.subject.otherBipolar Disorder
dc.subject.otherClozapine
dc.subject.otherCombined Modality Therapy
dc.subject.otherElectroconvulsive Therapy
dc.subject.otherHumans
dc.subject.otherLong-Term Care
dc.subject.otherMale
dc.titleCombined ECT and clozapine in treatment-resistant mania
dc.typeArticle
dspace.entity.typePublication
swu.datasource.scopushttps://www.scopus.com/inward/record.uri?eid=2-s2.0-0034199344&doi=10.1097%2f00124509-200006000-00013&partnerID=40&md5=df3a98fda3febcb668df544b04f22ddb

Files

Collections

Scopus: Year 1983-2021